http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1836 http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1836
Published: 23 September 2016
.....
Conclusions
Vitamin D deficiency was observed in the majority of HBV-infected patients and associated with adverse clinical outcomes. Our findings suggest that substitution of vitamin D may be a supportive option in the treatment of chronic liver diseases, in particular of HBV-associated disorders.
Our findings allow speculating that vitamin D and its analogs might provide a potential therapeutic addendum in the treatment of chronic liver diseases.
Full article can be found:
http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1836-